| Recent trends in targeting miRNAs for cancer therapy V Shah, J Shah Journal of Pharmacy and Pharmacology 72 (12), 1732-1749, 2020 | 111 | 2020 |
| Emerging role of Piezo ion channels in cardiovascular development V Shah, S Patel, J Shah Developmental Dynamics 251 (2), 276-286, 2022 | 24 | 2022 |
| Restoring ravaged heart: molecular mechanisms and clinical application of miRNA in heart regeneration V Shah, J Shah Frontiers in Cardiovascular Medicine 9, 835138, 2022 | 7 | 2022 |
| INF2 and ROBO2 gene mutation in an Indian family with end stage renal failure and follow‐up of renal transplantation V Shah, JK Singh, SK Srivastava, A Konnur, S Gang, SN Pandey Nephrology 29 (1), 48-54, 2024 | 2 | 2024 |
| CHEWING GUM: A BOON FOR ORAL DRUG DELIVERY V Shah, V Patel, J Shah, T Mehta Nirma University Journal of Pharmaceutical Sciences 4 (1), 3-18, 2017 | 1 | 2017 |
| Epigenetic Control of Redox Pathways in Cancer Progression V Shah, HY Lam, CHM Leong, R Sakaizawa, JS Shah, AP Kumar Antioxidants & Redox Signaling, 2025 | | 2025 |
| In Vivo Gene Therapy: AAV2 Vectors V Shah, J Shah Gene Delivery Systems, 223-241, 2022 | | 2022 |
| Gene Therapy for Cardiovascular Diseases: Clinical Evidences D Thakkar, V Shah, J Shah Gene Delivery, 71-84, 2022 | | 2022 |
| Safety and Toxicological Concerns Related to Nanoparticle-Based Lung Delivery H Memon, V Shah, T Mehta, J Shah Handbook of Lung Targeted Drug Delivery Systems, 631-642, 2021 | | 2021 |
| Nanoparticle-Based Lung Drug Delivery: A Clinical Perspective V Shah, J Shah Handbook of Lung Targeted Drug Delivery Systems, 643-651, 2021 | | 2021 |
Dr. Jigna ShahProfessor, Institute of Pharmacy, Nirma University, AhmedabadE-mail megerősítve itt: nirmauni.ac.in